Cargando…
Sequence of clinical and neurodegeneration events in Parkinson’s disease progression
Dementia is one of the most debilitating aspects of Parkinson’s disease. There are no validated biomarkers that can track Parkinson’s disease progression, nor accurately identify patients who will develop dementia and when. Understanding the sequence of observable changes in Parkinson’s disease in p...
Autores principales: | Oxtoby, Neil P, Leyland, Louise-Ann, Aksman, Leon M, Thomas, George E C, Bunting, Emma L, Wijeratne, Peter A, Young, Alexandra L, Zarkali, Angelika, Tan, Manuela M X, Bremner, Fion D, Keane, Pearse A, Morris, Huw R, Schrag, Anette E, Alexander, Daniel C, Weil, Rimona S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041043/ https://www.ncbi.nlm.nih.gov/pubmed/33543247 http://dx.doi.org/10.1093/brain/awaa461 |
Ejemplares similares
-
Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease
por: Hannaway, Naomi, et al.
Publicado: (2023) -
Visual tests predict dementia risk in Parkinson disease
por: Leyland, Louise-Ann, et al.
Publicado: (2020) -
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease
por: Thomas, George E C, et al.
Publicado: (2021) -
Visual dysfunction in Parkinson’s disease
por: Weil, Rimona S., et al.
Publicado: (2016) -
Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease
por: Zarkali, Angeliki, et al.
Publicado: (2021)